SPONSOR
Shanghai Synvida Biotechnology Co.,Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1, EARLY_Phase 1
Conditions studied: Idiopathic Pulmonary Fibrosis(IPF)Healthy ParticipantsIdiopathic Pulmonary Fibrosis
Clinical Trials by Shanghai Synvida Biotechnology Co.,Ltd.
NCT07121413 Phase 2
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis(IPF)
NCT07469085 Phase 1
Recruiting
A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants.
Healthy Participants
NCT06267183 EARLY_Phase 1
Recruiting
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
Idiopathic Pulmonary Fibrosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology